Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials

This publication has 26 references indexed in Scilit:

• Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
  New England Journal of Medicine, 2001
• Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial
  Journal of Bone and Mineral Research, 2000
• Risedronate Reverses Bone Loss in Postmenopausal Women with Low Bone Mass: Results From a Multinational, Double-Blind, Placebo-Controlled Trial
  Journal of Clinical Endocrinology & Metabolism, 2000
• Bisphosphonates in the treatment of osteoporosis in 1997: a review
  Current Therapeutic Research, 1997
• Esophagitis Associated with the Use of Alendronate
  New England Journal of Medicine, 1996
• Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
  Bone, 1996
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
  New England Journal of Medicine, 1995
• Oral bisphosphonates in the treatment of osteoporosis: a review
  Current Therapeutic Research, 1995
• Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
  BMJ, 1987
• Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.
  BMJ, 1984